Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in Japan
Clinical trial NCT07216079 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07216079
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-15
- Primary completion
- 2026-11-30
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.